Vivoryon Therapeutics Launches Capital Increase by Way of an Accelerated Bookbuild Offering

Vivoryon Therapeutics N.V. Reports Q1 2023 Financial Results and Highlights Operational Progress

Vivoryon Therapeutics Successfully Completes Private Placement Raising EUR 25 Million